Cargando…
Building the drug-GO function network to screen significant candidate drugs for myasthenia gravis
Myasthenia gravis (MG) is an autoimmune disease. In recent years, considerable evidence has indicated that Gene Ontology (GO) functions, especially GO-biological processes, have important effects on the mechanisms and treatments of different diseases. However, the roles of GO functions in the pathog...
Autores principales: | Li, Shuang, Cao, Yuze, Li, Lei, Zhang, Huixue, Lu, Xiaoyu, Bo, Chunrui, Kong, Xiaotong, Liu, Zhaojun, Chen, Lixia, Liu, Peifang, Jiao, Yang, Wang, Jianjian, Ning, Shangwei, Wang, Lihua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6448860/ https://www.ncbi.nlm.nih.gov/pubmed/30947317 http://dx.doi.org/10.1371/journal.pone.0214857 |
Ejemplares similares
-
Construction of an miRNA-regulated drug-pathway network reveals drug repurposing candidates for myasthenia gravis
por: Cao, Yuze, et al.
Publicado: (2017) -
Construction of a TF–miRNA–gene feed-forward loop network predicts biomarkers and potential drugs for myasthenia gravis
por: Bo, Chunrui, et al.
Publicado: (2021) -
Detecting Key Genes Regulated by miRNAs in Dysfunctional Crosstalk Pathway of Myasthenia Gravis
por: Cao, Yuze, et al.
Publicado: (2015) -
Corrigendum to “Detecting Key Genes Regulated by miRNAs in Dysfunctional Crosstalk Pathway of Myasthenia Gravis”
por: Cao, Yuze, et al.
Publicado: (2017) -
Response to: Comment on “Detecting Key Genes Regulated by miRNAs in Dysfunctional Crosstalk Pathway of Myasthenia Gravis”
por: Cao, Yuze, et al.
Publicado: (2017)